MetLife, Inc.

MetLife's RSI of 69.0 signals overbought territory, yet the stock trades at a modest 15.5x earnings—a valuation that doesn't scream overextension. With market cap of $48.2B and only 1.94% short interest, there's minimal squeeze risk and limited bearish conviction. The disconnect between momentum extremes and reasonable valuation multiples suggests either strong fundamental momentum justifying the technical froth, or a potential mean-reversion setup if sentiment shifts. Being below its 52-week high keeps upside optionality intact, though the elevated RSI warrants caution on new longs at current levels.